{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:20:55Z","timestamp":1718583655580},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,15]]},"DOI":"10.7759\/cureus.62454","type":"journal-article","created":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T03:19:39Z","timestamp":1718507979000},"source":"Crossref","is-referenced-by-count":0,"title":["Changing Paradigm of Yeast Isolates in HIV-Seropositive Patients with Oropharyngeal Candidiasis (OPC)"],"prefix":"10.7759","author":[{"given":"Nitali","family":"Arun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh","family":"Rajpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria","volume":"8","author":"Enwuru CA","year":"2008","unstructured":"Enwuru CA, Ogunledun A, Idika N, Enwuru NV, Ogbonna F, Aniedobe M, Adeiga A. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci. 2008, 8:142-8.","journal-title":"Afr Health Sci"},{"key":"ref2","article-title":"Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV infected individuals","volume":"131","author":"Mane A","year":"2010","unstructured":"Mane A, Panchvalli S, Bembalkar S, Risbud A. Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV infected individuals. Indian J Med Res. 2010, 131:836-8.","journal-title":"Indian J Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2000.tb00326.x","article-title":"Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients","volume":"6","author":"Ranganathan K","year":"2000","unstructured":"Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis. 2000, 6:152-7. 10.1111\/j.1601-0825.2000.tb00326.x","journal-title":"Oral Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-135","article-title":"Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis","volume":"8","author":"Hamza OJ","year":"2008","unstructured":"Hamza OJ, Matee MI, Moshi MJ, et al.. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol. 2008, 8:135. 10.1186\/1471-2180-8-135","journal-title":"BMC Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller MA","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007, 20:133-63. 10.1128\/CMR.00029-06","journal-title":"Clin Microbiol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections","volume":"24","author":"Rex JH","year":"1997","unstructured":"Rex JH, Pfaller MA, Galgiani JN, et al.. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Clin Infect Dis. 1997, 24:235-47. 10.1093\/clinids\/24.2.235","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/hiv.s6660","article-title":"Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection","volume":"2","author":"Vazquez JA","year":"2010","unstructured":"Vazquez JA. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl). 2010, 2:89-101. 10.2147\/hiv.s6660","journal-title":"HIV AIDS (Auckl)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas PG","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al.. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 62:e1-50. 10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-82","article-title":"Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia","volume":"13","author":"Mulu A","year":"2013","unstructured":"Mulu A, Kassu A, Anagaw B, et al.. Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC Infect Dis. 2013, 13:82. 10.1186\/1471-2334-13-82","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup MC","year":"2017","unstructured":"Arendrup MC, Patterson TF. Multidrug-resistant candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017, 216:S445-51. 10.1093\/infdis\/jix131","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.80","article-title":"Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans","volume":"12","author":"Fidel PL Jr","year":"1999","unstructured":"Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999, 12:80-96. 10.1128\/CMR.12.1.80","journal-title":"Clin Microbiol Rev"},{"key":"ref12","unstructured":"National AIDS Control Organization. Operational guidelines for integrated counseling and testing centers. (2011). Accessed. February 21, 2023: https:\/\/naco.gov.in\/sites\/default\/files\/National%20HIV%20Counselling%20&%20Testing%20Services%20Guideline,%20Dec%2020...."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2008.01542.x","article-title":"Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina","volume":"52","author":"Luque AG","year":"2009","unstructured":"Luque AG, Biasoli MS, Tosello ME, Binolfi A, Lupo S, Magar\u00f3 HM. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina. Mycoses. 2009, 52:53-9. 10.1111\/j.1439-0507.2008.01542.x","journal-title":"Mycoses"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2003.10.003","article-title":"The role of antifungal susceptibility testing in the therapy of candidiasis","volume":"48","author":"Hospenthal DR","year":"2004","unstructured":"Hospenthal DR, Murray CK, Rinaldi MG. The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis. 2004, 48:153-60. 10.1016\/j.diagmicrobio.2003.10.003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.192969","article-title":"Identification and antifungal susceptibility testing of Candida species: a comparison of Vitek-2 system with conventional and molecular methods","volume":"8","author":"Kaur R","year":"2016","unstructured":"Kaur R, Dhakad MS, Goyal R, Haque A, Mukhopadhyay G. Identification and antifungal susceptibility testing of Candida species: a comparison of Vitek-2 system with conventional and molecular methods. J Glob Infect Dis. 2016, 8:139-46. 10.4103\/0974-777X.192969","journal-title":"J Glob Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/lam.13052","article-title":"Iranian HIV\/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species","volume":"67","author":"Khedri S","year":"2018","unstructured":"Khedri S, Santos AL, Roudbary M, et al.. Iranian HIV\/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Lett Appl Microbiol. 2018, 67:392-9. 10.1111\/lam.13052","journal-title":"Lett Appl Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.46829\/hsijournal.2020.6.1.1.43-49","article-title":"Distribution and susceptibility profile of Candida isolates from HIV patients with oropharyngeal candidiasis","volume":"1","author":"Quansah H","year":"2020","unstructured":"Quansah H, Opintan J. Distribution and susceptibility profile of Candida isolates from HIV patients with oropharyngeal candidiasis. HSI Journal. 2020, 1:43-9. 10.46829\/hsijournal.2020.6.1.1.43-49","journal-title":"HSI Journal"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.14260\/jemds\/2021\/76","article-title":"Study of oral candidiasis in HIV\/AIDS patients and their antifungal susceptibility pattern","volume":"10","author":"Hodiwala AVB","year":"2021","unstructured":"Hodiwala AVB, Kar HB, Singh A, et al.. Study of oral candidiasis in HIV\/AIDS patients and their antifungal susceptibility pattern. J Evolution Med Dent Sci. 2021, 10:338-41. 10.14260\/jemds\/2021\/76","journal-title":"J Evolution Med Dent Sci"},{"key":"ref19","article-title":"Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients","volume":"40","author":"Maninder J","year":"2008","unstructured":"Maninder J, Usha A. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients. J Commun Dis. 2008, 40:177-81.","journal-title":"J Commun Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac072.P350","article-title":"P350 oropharyngeal candidiasis in HIV infected patients: associated risk factors and antifungal susceptibility testing of candida species by disc diffusion method","volume":"60","author":"Chaudhary P","year":"2022","unstructured":"Chaudhary P, Basnet S, Chaulagain M, Khadgi A, B.K S. P350 oropharyngeal candidiasis in HIV infected patients: associated risk factors and antifungal susceptibility testing of candida species by disc diffusion method. Med Mycol. 2022, 60:10.1093\/mmy\/myac072.P350","journal-title":"Med Mycol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5923\/j.medicine.20130201.01","article-title":"Oral and urinary colonisation of Candida species in hiv\/aids patients in Cameroon","volume":"2(1)","author":"Njunda LA","year":"2013","unstructured":"Njunda LA, Assob JCN, Nsagha SD, Kamga HLF, Ndellejong EC, Kwenti TE. Oral and urinary colonisation of Candida species in hiv\/aids patients in Cameroon. Basic Sciences of Medicine. 2013, 2(1):1-8. 10.5923\/j.medicine.20130201.01","journal-title":"Basic Sciences of Medicine"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00298","article-title":"Antifungal drug susceptibility of Candida species isolated from HIV-positive patients recruited at a public hospital in S\u00e3o Lu\u00eds, Maranh\u00e3o, Brazil","volume":"8","author":"Ter\u00e7as AL","year":"2017","unstructured":"Ter\u00e7as AL, Marques SG, Moffa EB, Alves MB, de Azevedo CM, Siqueira WL, Monteiro CA. Antifungal drug susceptibility of Candida species isolated from HIV-positive patients recruited at a public hospital in S\u00e3o Lu\u00eds, Maranh\u00e3o, Brazil. Front Microbiol. 2017, 8:298. 10.3389\/fmicb.2017.00298","journal-title":"Front Microbiol"},{"key":"ref23","article-title":"Species distribution, virulence factors and antifungal susceptibility profile of Candida isolated from oropharyngeal lesions of HIV infected patients","volume":"3","author":"Aher CS","year":"2014","unstructured":"Aher CS. Species distribution, virulence factors and antifungal susceptibility profile of Candida isolated from oropharyngeal lesions of HIV infected patients. Int J Curr Microbiol App Sci. 2014, 3:453-60.","journal-title":"Int J Curr Microbiol App Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261427-changing-paradigm-of-yeast-isolates-in-hiv-seropositive-patients-with-oropharyngeal-candidiasis-opc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T03:19:45Z","timestamp":1718507985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261427-changing-paradigm-of-yeast-isolates-in-hiv-seropositive-patients-with-oropharyngeal-candidiasis-opc"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.62454","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,15]]}}}